InsidersTradesSigma
Browse the full directors' dealings record of EQL Pharma AB, a listed equity based in Finland. Shares are quoted on FI FI, under the oversight of FIN-FSA. Operating in the Healthcare sector, EQL Pharma AB has recorded 3 reports. Market capitalisation: €772.2m. The latest transaction was disclosed on 30 December 2025 — Purchase. Among the most active insiders: Martin Kristofferson. Every trade is accessible without an account.
FY ended March 2025 · cache
0 of 0 declarations